NO167390C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-(2-pyrimidinyl)-1-piperazinyl heterocykliske carbonylderivater. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-(2-pyrimidinyl)-1-piperazinyl heterocykliske carbonylderivater.

Info

Publication number
NO167390C
NO167390C NO870891A NO870891A NO167390C NO 167390 C NO167390 C NO 167390C NO 870891 A NO870891 A NO 870891A NO 870891 A NO870891 A NO 870891A NO 167390 C NO167390 C NO 167390C
Authority
NO
Norway
Prior art keywords
pyrimidinyl
preparation
heterocyclic carbonyl
therapeutic active
carbonyl derivatives
Prior art date
Application number
NO870891A
Other languages
English (en)
Other versions
NO870891D0 (no
NO870891L (no
NO167390B (no
Inventor
Marcel Hibert
Maurice W Gittos
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO870891D0 publication Critical patent/NO870891D0/no
Publication of NO870891L publication Critical patent/NO870891L/no
Publication of NO167390B publication Critical patent/NO167390B/no
Publication of NO167390C publication Critical patent/NO167390C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO870891A 1986-03-05 1987-03-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-(2-pyrimidinyl)-1-piperazinyl heterocykliske carbonylderivater. NO167390C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83627786A 1986-03-05 1986-03-05

Publications (4)

Publication Number Publication Date
NO870891D0 NO870891D0 (no) 1987-03-04
NO870891L NO870891L (no) 1987-09-07
NO167390B NO167390B (no) 1991-07-22
NO167390C true NO167390C (no) 1991-10-30

Family

ID=25271609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870891A NO167390C (no) 1986-03-05 1987-03-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-(2-pyrimidinyl)-1-piperazinyl heterocykliske carbonylderivater.

Country Status (18)

Country Link
EP (1) EP0238905B1 (no)
JP (1) JPH0778043B2 (no)
KR (1) KR900000413B1 (no)
CN (1) CN1023484C (no)
AR (2) AR242678A1 (no)
AT (1) ATE93523T1 (no)
AU (1) AU588671B2 (no)
CA (1) CA1286667C (no)
DE (1) DE3787109T2 (no)
DK (1) DK111987A (no)
ES (1) ES2059316T3 (no)
FI (1) FI870925A (no)
HU (1) HU197567B (no)
NO (1) NO167390C (no)
NZ (1) NZ219456A (no)
PH (1) PH24912A (no)
PT (1) PT84408B (no)
ZA (1) ZA871450B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208690B (en) * 1987-10-26 1993-12-28 Pfizer Process for producing 1-hjeterocyclic sulfonyl-3-(pyrimidinyl piperazinyl)-propane derivatives and pharmaceutical compositions comprising same
SE8803429D0 (sv) * 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
DE69033393T2 (de) * 1989-04-22 2000-05-25 Wyeth John & Brother Ltd Tertiäre alkyl funktionalisierte Piperazin-Derivate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
DE2727469A1 (de) * 1977-06-18 1978-12-21 Hoechst Ag Neue hexahydropyrimidine, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
HU208690B (en) * 1987-10-26 1993-12-28 Pfizer Process for producing 1-hjeterocyclic sulfonyl-3-(pyrimidinyl piperazinyl)-propane derivatives and pharmaceutical compositions comprising same
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives

Also Published As

Publication number Publication date
EP0238905A2 (en) 1987-09-30
JPS62265285A (ja) 1987-11-18
KR870008874A (ko) 1987-10-21
DE3787109T2 (de) 1994-02-10
DK111987A (da) 1987-09-06
HU197567B (en) 1989-04-28
ZA871450B (en) 1987-08-20
FI870925A (fi) 1987-09-06
PH24912A (en) 1990-12-26
AR242678A1 (es) 1993-04-30
NO870891D0 (no) 1987-03-04
ES2059316T3 (es) 1994-11-16
CA1286667C (en) 1991-07-23
ATE93523T1 (de) 1993-09-15
JPH0778043B2 (ja) 1995-08-23
AR242790A1 (es) 1993-05-31
AU6960787A (en) 1987-09-10
EP0238905A3 (en) 1989-08-09
DK111987D0 (da) 1987-03-04
NO870891L (no) 1987-09-07
HUT43591A (en) 1987-11-30
DE3787109D1 (de) 1993-09-30
CN1023484C (zh) 1994-01-12
FI870925A0 (fi) 1987-03-03
NO167390B (no) 1991-07-22
EP0238905B1 (en) 1993-08-25
PT84408A (en) 1987-04-01
CN87101688A (zh) 1988-03-02
AU588671B2 (en) 1989-09-21
KR900000413B1 (ko) 1990-01-30
NZ219456A (en) 1989-08-29
PT84408B (pt) 1989-10-04

Similar Documents

Publication Publication Date Title
NO167142C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO895086L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO165344C (no) Analogifremgangsmaate for fremstilling av teraputisk aktive indolizin-derivater.
NO164097C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater.
NO170884C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
NO871879D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive heterocykliske forbindelser.
NO871588D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO900795L (no) Fremgangsmaate for fremstilling av nye 2-(1-piperazinyl)-4-fenylcykloalkanpyrimidinderivater.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO167204C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diacylderivater av 4-(trialkylbenzyl)-piperazinylforbindelser.
NO871044D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO155137C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av 2-(4-piperidyl)-1-(4-kinolyl)-etanon.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO154054C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater.
NO900919L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske etere.
NO168037C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO171065C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
NO169007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater
NO884175D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO169962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
NO167390C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-(2-pyrimidinyl)-1-piperazinyl heterocykliske carbonylderivater.
NO171501C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-metoksymetylpenem-derivater